Publications by authors named "Meghan Thompson"

Claim this Profile
E
Epcoritamab monotherapy for Richter transformation (EPCORE CLL-1): findings from a single-arm, multicentre, open-label, phase 1b/2 trial.
Arnon P Kater, Ann Janssens, Herbert Eradat, Fritz Offner, Jose D Sandoval-Sus, Meghan C Thompson

Lancet Haematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure.
Kuo-Kai Chin, Brian J Ball, Yasmin Abaza, Jessica K Altman, Rahul K Thakur, Meghan C Thompson

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Relapsed and/or Refractory Chronic Lymphocytic Leukemia.
Allison Kagerer, Meghan C Thompson

Hematol Oncol Clin North Am· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era.
Cecelia R Miller, Ying Huang, John N Allan, Seema A Bhat, David Bond, Meghan C Thompson, Philip A Thompson

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs.
Hannah Burton, Leora Boussi, David Nemirovsky, Andriy Derkach, Jenna Ciervo, Meghan C Thompson

Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can We Borrow Your Intervention? Randomized Controlled Trial of an Older Adult Telehealth Wellness Promotion Program Adapted for Middle-Aged Adults With Physical Disability.
Ivan R Molton, Katie Singsank, Nova Rivera, Leah A Munroe, Aaron Flaster, Meghan Thompson

Gerontologist· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BTK Inhibitors Versus Venetoclax as First- or Second-Line Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Evidence Study.
Lindsey E Roeker, Yi Han, Anna Teschemaker, Anthony R Mato, Meghan C Thompson

Am J Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies.
Lindsey E Roeker, Catherine C Coombs, Nirav N Shah, Wojciech Jurczak, Jennifer A Woyach, Meghan C Thompson

Acta Haematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus recommendations from the 2024 Lymphoma Research Foundation workshop on treatment selection and sequencing in CLL or SLL.
Jacob D Soumerai, Jacqueline Barrientos, Inhye Ahn, Catherine Coombs, Douglas Gladstone, Meghan Thompson

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.
Adam S Kittai, Ying Huang, Sarah Miller, John N Allan, Seema A Bhat, Meghan C Thompson, Philip A Thompson

Blood Cancer J· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial.
Nirav N Shah, Michael Wang, Lindsey E Roeker, Krish Patel, Jennifer A Woyach, Meghan C Thompson

Haematologica· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia.
Michele D Stanchina, Skye Montoya, Alexey V Danilov, Jorge J Castillo, Alvaro J Alencar, Meghan Thompson

Nat Rev Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax.
Yannis K Valtis, David Nemirovsky, Andriy Derkach, Saumya Sharan, Charlene Kabel, Meghan C Thompson

Blood Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings.
Ozge Ceyhan-Birsoy, Elise Fiala, Satshil Rana, Margaret Sheehan, Jennifer Kennedy, Meghan C Thompson

Haematologica· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
William G Wierda, Jennifer Brown, Jeremy S Abramson, Farrukh Awan, Syed F Bilgrami, Meghan Thompson

J Natl Compr Canc Netw· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel identification of t(14;18)(q32;q21)/IGH::MALT1 in chronic lymphocytic leukaemia.
Jyoti Kumar, Mark D Ewalt, Yanming Zhang, JinJuan Yao, Meghan C Thompson

Br J Haematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.
Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson

Science· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Covalent Bruton's Tyrosine Kinase Inhibitors in the Treatment of Chronic Lymphocytic Leukemia.
Skye Montoya, Meghan C Thompson

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of the Program to Encourage Active, Rewarding Lives (PEARLS) to reduce depression: a multi-state evaluation.
Matthew Lee Smith, Lesley E Steinman, Carol N Montoya, Meghan Thompson, Lixian Zhong

Front Public Health· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approach to a patient with "double refractory" chronic lymphocytic leukemia: "Double, double toil and trouble" (Shakespeare).
Julia H Aronson, Sigrid S Skånland, Lindsey E Roeker, Meghan C Thompson, Anthony R Mato

Am J Hematol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach.
Lindsey E Roeker, Tatyana A Feldman, Jacob D Soumerai, Victoria Falco, Gail Panton, Meghan C Thompson

Clin Cancer Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen.
Meghan C Thompson, Rosemary A Harrup, Catherine C Coombs, Lindsey E Roeker, Jeffrey J Pu

Blood Adv· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Directions for Mantle Cell Lymphoma in 2022.
Anita Kumar, Toby A Eyre, Katharine L Lewis, Meghan C Thompson, Chan Y Cheah

Am Soc Clin Oncol Educ Book· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Treatment of Chronic Lymphocytic Leukemia: The Diminishing Role of Chemoimmunotherapy.
Lindsey E Roeker, Meghan Thompson, Anthony R Mato

Drugs· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors.
Eric Wang, Xiaoli Mi, Meghan C Thompson, Skye Montoya, Ryan Q Notti

N Engl J Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis